LFMD
Get informed when a big investor buys or sells
+ Follow| Market cap | $206.99 Million |
|---|---|
| Enterprise Value | $190.70 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.23 |
| Beta | 2.02 |
| Outstanding Shares | 47,336,060 |
| P/E Ratio | -12.47 |
|---|---|
| PEG | 1.56 |
| Price to Sales | 1.52 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.15 |
| Enterprise Value to EBIT | -9.96 |
| Enterprise Value to Net Income | 52 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 1.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6765▼ 15.52% |
|---|---|
| Total Calls | 301,100▼ 3.46% |
| Total Puts | 203,700▼ 21.47% |
Holdings and activity of institutional investors.
| Ownership % | 38.13%▼ 2.92% |
|---|---|
| Total Invested | $64.38M▼ 0.37% |
| Investors Holding | 107▼ 3.00% |
No data
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordab...